Stay updated with breaking news from Henrik harling. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
2cureX is proud to announce that it has been able to predict response to anti-angiogenic drugs with a modified version of its IndiTreat® technology. The development could be the basis for a new product addressing this drug class. The results have been published together with Rigshospitalet, Bispebjerg Hospital, University of Copenhagen and University of Bristol. ....